Tsu‐An Hsu

1.1k total citations
28 papers, 804 citations indexed

About

Tsu‐An Hsu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Tsu‐An Hsu has authored 28 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Tsu‐An Hsu's work include Viral Infectious Diseases and Gene Expression in Insects (8 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (5 papers). Tsu‐An Hsu is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (8 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (5 papers). Tsu‐An Hsu collaborates with scholars based in Taiwan, United States and Japan. Tsu‐An Hsu's co-authors include Shin‐Ru Shih, Michael J. Betenbaugh, Jyh‐Haur Chern, Chung-Chi Lee, Yen‐Chun Lee, Erik M. Whiteley, Yu‐Sheng Chao, Chiann-Chyi Chen, Jin‐Ching Lee and Shih‐Cheng Chang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Tsu‐An Hsu

28 papers receiving 786 citations

Peers

Tsu‐An Hsu
Amartya Basu United States
Pierre Redelinghuys South Africa
Sunil Kadam United States
Joseph Marakovits United States
Tsu‐An Hsu
Citations per year, relative to Tsu‐An Hsu Tsu‐An Hsu (= 1×) peers Pengfei Fang

Countries citing papers authored by Tsu‐An Hsu

Since Specialization
Citations

This map shows the geographic impact of Tsu‐An Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsu‐An Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsu‐An Hsu more than expected).

Fields of papers citing papers by Tsu‐An Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsu‐An Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsu‐An Hsu. The network helps show where Tsu‐An Hsu may publish in the future.

Co-authorship network of co-authors of Tsu‐An Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Tsu‐An Hsu. A scholar is included among the top collaborators of Tsu‐An Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsu‐An Hsu. Tsu‐An Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mu‐Chun, Mohane Selvaraj Coumar, Shu‐Yu Lin, et al.. (2023). Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 66(4). 2566–2588. 10 indexed citations
2.
Lo, Chen‐Fu, Yu‐Tzu Liu, Kuan-Liang Liu, et al.. (2022). Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate. Journal of Medicinal Chemistry. 65(19). 12802–12824. 8 indexed citations
3.
Huang, Chiung‐Yi, Shu‐Yu Lin, Tsu‐An Hsu, Hsing‐Pang Hsieh, & Ming‐Hsi Huang. (2021). Colloidal Assemblies Composed of Polymeric Micellar/Emulsified Systems Integrate Cancer Therapy Combining a Tumor-Associated Antigen Vaccine and Chemotherapeutic Regimens. Nanomaterials. 11(7). 1844–1844. 2 indexed citations
4.
Chen, Lili, et al.. (2019). Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology. 12(1). 138–138. 44 indexed citations
5.
Yeh, Teng‐Kuang, Iou‐Jiun Kang, Tsu‐An Hsu, et al.. (2019). A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus. European Journal of Medicinal Chemistry. 167. 245–268. 7 indexed citations
6.
Tsai, Hui‐Jen, Weir‐Torn Jiaang, Neng‐Yao Shih, et al.. (2018). BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor. Cancer Science. 109(11). 3591–3601. 4 indexed citations
7.
Kang, Iou‐Jiun, Tsu‐An Hsu, Andrew Yueh, et al.. (2011). Isatin-β-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(7). 1948–1952. 63 indexed citations
8.
Kang, Iou‐Jiun, Liwen Wang, Chung-Chi Lee, et al.. (2009). Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4134–4138. 9 indexed citations
9.
Kang, Iou‐Jiun, Liwen Wang, Chung-Chi Lee, et al.. (2009). Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(21). 6063–6068. 27 indexed citations
10.
Kang, Iou‐Jiun, Liwen Wang, Chung-Chi Lee, et al.. (2009). Design, synthesis, and anti-HCV activity of thiourea compounds. Bioorganic & Medicinal Chemistry Letters. 19(7). 1950–1955. 40 indexed citations
11.
Chern, Jyh‐Haur, Kak‐Shan Shia, Tsu‐An Hsu, et al.. (2004). Design, synthesis, and structure–activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(10). 2519–2525. 101 indexed citations
12.
Wu, Jyh-Ming, Tsu‐An Hsu, & Cheng‐Kang Lee. (2003). Expression of the gene coding for bacterial hemoglobin improves β-galactosidase production in a recombinant Pichia pastoris. Biotechnology Letters. 25(17). 1457–1462. 23 indexed citations
13.
Li, Meiling, Tsu‐An Hsu, Tzu‐Chun Chen, et al.. (2002). The 3C Protease Activity of Enterovirus 71 Induces Human Neural Cell Apoptosis. Virology. 293(2). 386–395. 145 indexed citations
14.
Whiteley, Erik M., Tsu‐An Hsu, & Michael J. Betenbaugh. (1997). Modeling assembly, aggregation, and chaperoning of immunoglobulin G production in insect cells. Biotechnology and Bioengineering. 56(1). 106–116. 15 indexed citations
15.
Whiteley, Erik M., Tsu‐An Hsu, & Michael J. Betenbaugh. (1997). Thioredoxin Domain Non-equivalence and Anti-chaperone Activity of Protein Disulfide Isomerase Mutants in Vivo. Journal of Biological Chemistry. 272(36). 22556–22563. 22 indexed citations
16.
Hsu, Tsu‐An, Noriko Takahashi, Yoshinori Tsukamoto, et al.. (1997). Differential N-Glycan Patterns of Secreted and Intracellular IgG Produced in Trichoplusia ni Cells. Journal of Biological Chemistry. 272(14). 9062–9070. 83 indexed citations
17.
Whiteley, Erik M., Tsu‐An Hsu, & Michael J. Betenbaugh. (1997). Modeling assembly, aggregation, and chaperoning of immunoglobulin G production in insect cells. Biotechnology and Bioengineering. 56(1). 106–116. 1 indexed citations
18.
Betenbaugh, Michael J., Eric Ailor, Erik M. Whiteley, Paul M. Hinderliter, & Tsu‐An Hsu. (1996). Chaperone and foldase coexpression in the baculovirus-insect cell expression system. Cytotechnology. 20(1-3). 149–159. 12 indexed citations
19.
Hsu, Tsu‐An, Sarah Watson, Joseph J. Eiden, & Michael J. Betenbaugh. (1996). Rescue of Immunoglobulins from Insolubility Is Facilitated by PDI in the Baculovirus Expression System. Protein Expression and Purification. 7(3). 281–288. 38 indexed citations
20.
Hsu, Tsu‐An, Kathryn M. Carbone, Steven A. Rubin, Steven Vonderfecht, & Joseph Eiden. (1994). Borna Disease Virus p24 and p38/40 Synthesized in a Baculovirus Expression System: Virus Protein Interactions in Insect and Mammalian Cells. Virology. 204(2). 854–859. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026